Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citius Pharmaceuticals Inc (CTXR) vs ProShares Ultra Gold ETF (UGL) Price & Performance

Citius Pharmaceuticals IncTrade
ProShares Ultra Gold ETFTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs ProShares Ultra Gold ETF — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while ProShares Ultra Gold ETF trades at $52.36. The key difference: ProShares Ultra Gold ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

CTXRUGL
Market Cap
$20.01M
Sector
HealthLeveraged / Inverse
52-Week High
$1.82$85.62
52-Week Low
$0.48$34.37
Enterprise Value
$16.23M

Returns comparison

Trailing returns across standard periods

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR

About ProShares Ultra Gold ETF

UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.

Read more on UGL